Source: Eur Respir J 2004; 23: 752-758
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sztrymf B., Rabiller A., Nunes H., Savale L., Lebrec D., Le Pape A., de Montpreville V., Mazmanian M., Humbert M., Herve P.. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. Eur Respir J 2004; 23: 752-758

Member's Comments

No comment yet.

Related content which might interest you: Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2009; 34: 731 Year: 2009 Role of nitric oxide in hepatopulmonary syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 546s Year: 2006 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Effects of nitric oxide synthesis inhibition on pulmonary gas exchange in hepatopulmonary syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 562s Year: 2004 Role of tumor necrosis factor alpha in hepatopulmonary syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 562s Year: 2004 Hepatopulmonary syndrome in patients listed for liver transplantation Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Inhibition of nitric oxide production during inflammation associated with hypoxemia reduces the survival after apnea in rats. Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients Source: Eur Respir J 2008; 31: 815-821 Year: 2008 Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Inducible nitric oxide synthase inhibition reduces eosinophilic and lymphocytic recruitment to lung parenchyma in guinea pigs with chronic pulmonary inflammation Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 The hepatopulmonary syndrome Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=112 Year: 2005 Nitric oxide synthase gene expression and its relation with the lung vascular injury in pneumonia of immunosupressed rats Source: Eur Respir J 2005; 26: Suppl. 49, 731s Year: 2005 Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016 Hypoxia inducible factor-1? in human emphysema lung tissue Source: Eur Respir J 2011; 37: 775-783 Year: 2011 Prognostic evaluation of alveolar concentration of nitric oxide, serum periostin and CD59 in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Effect of fulvestrant in an experimental model of hepato-pulmonary syndrome (HPS) in rats Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Source: Eur Respir J 2003; 21: 394-400 Year: 2003 Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 Inhaled vasodilators in acute lung injury Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=129 Year: 2002